aid: reven-pharmaceuticals
name: Reven Pharmaceuticals
description: >-
  Reven Pharmaceuticals is a privately held, clinical-stage biopharmaceutical company founded in 1999 and
  headquartered in Broomfield, Colorado. Reven develops medicines from its proprietary RJX Technology
  platform - a patented, first-in-class intravenous composition of anti-oxidant and anti-inflammatory
  ingredients - and is advancing candidates for sepsis, multi-system inflammation, cytokine release
  syndrome, ARDS and vascular, oncology, CNS and ocular indications. Its lead candidate, Rejuveinix (RJX),
  completed a double-blind, placebo-controlled Phase 1 dose-escalation study in healthy volunteers and
  received FDA clearance of an Investigational New Drug application for the treatment of COVID-19. Reven
  publishes a corporate and investor website at reven.com covering its pipeline, modalities, clinical
  trials, expanded-access program and news, but operates no public developer program, API, SDK or
  machine-readable interface of any kind.
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
image: https://reven.com/wp-content/uploads/2021/12/Reven_Logo_Header-1.png
url: https://raw.githubusercontent.com/api-evangelist/reven-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Clinical Trials
- Drug Development
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/reven-pharmaceuticals-domain-security.yml
- type: Website
  url: https://reven.com/
- type: Blog
  url: https://reven.com/news/
- type: BlogRSS
  url: https://reven.com/feed/
- type: Support
  url: https://reven.com/contact-us/
- type: LinkedIn
  url: https://www.linkedin.com/company/revenpharmaceuticals
- type: SecondaryMarket
  url: https://forgeglobal.com/reven-pharmaceuticals_stock/
- type: LLMsTxt
  url: llms/reven-pharmaceuticals-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Reven is a 15-person clinical-stage drug developer whose product is an IV pharmaceutical (RJX), not
    software - reven.com is a WordPress corporate/investor site where every contract-discovery path 404s
    and the only machine-readable endpoint is the CMS's own default /wp-json/ (228 WordPress core and
    plugin routes, no Reven product).
  evidence:
  - url: https://reven.com/openapi.json
    status: 404
  - url: https://reven.com/graphql
    status: 404
  - url: https://reven.com/.well-known/agent-card.json
    status: 404
  - url: https://reven.com/llms.txt
    status: 404
  - url: https://reven.com/wp-json/
    status: 200
  checked: '2026-08-26'